LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 286 of 535
Next
>>
>
7126 to 7150 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	KIN001-043	10	uM	LJP6	1	C07	72	hr	1097	1595	3610	0.4418	0.2432
BT-20	KIN001-043	10	uM	LJP6	2	C07	72	hr	1097	1599	3713	0.4306	0.2387
BT-20	KIN001-043	10	uM	LJP6	3	C07	72	hr	1097	1671	3696	0.4521	0.2713
BT-20	Saracatinib	0.04	uM	LJP6	1	D12	72	hr	1097	3604	3610	0.9982	0.9979
BT-20	Saracatinib	0.04	uM	LJP6	2	D12	72	hr	1097	3541	3713	0.9535	0.9466
BT-20	Saracatinib	0.04	uM	LJP6	3	D12	72	hr	1097	3354	3696	0.9074	0.8921
BT-20	Saracatinib	0.12	uM	LJP6	1	D11	72	hr	1097	3484	3610	0.9649	0.9589
BT-20	Saracatinib	0.12	uM	LJP6	2	D11	72	hr	1097	3603	3713	0.9702	0.9659
BT-20	Saracatinib	0.12	uM	LJP6	3	D11	72	hr	1097	3223	3696	0.8719	0.8495
BT-20	Saracatinib	0.37	uM	LJP6	1	D10	72	hr	1097	3290	3610	0.9112	0.8947
BT-20	Saracatinib	0.37	uM	LJP6	2	D10	72	hr	1097	3131	3713	0.8431	0.8151
BT-20	Saracatinib	0.37	uM	LJP6	3	D10	72	hr	1097	3102	3696	0.8392	0.8096
BT-20	Saracatinib	1.11	uM	LJP6	1	D09	72	hr	1097	2893	3610	0.8013	0.7580
BT-20	Saracatinib	1.11	uM	LJP6	2	D09	72	hr	1097	2975	3713	0.8011	0.7631
BT-20	Saracatinib	1.11	uM	LJP6	3	D09	72	hr	1097	2796	3696	0.7564	0.7054
BT-20	Saracatinib	3.33	uM	LJP6	1	D08	72	hr	1097	2154	3610	0.5966	0.4807
BT-20	Saracatinib	3.33	uM	LJP6	2	D08	72	hr	1097	2619	3713	0.7052	0.6398
BT-20	Saracatinib	3.33	uM	LJP6	3	D08	72	hr	1097	2242	3696	0.6065	0.5035
BT-20	Saracatinib	10	uM	LJP6	1	D07	72	hr	1097	1699	3610	0.4706	0.2898
BT-20	Saracatinib	10	uM	LJP6	2	D07	72	hr	1097	1591	3713	0.4284	0.2352
BT-20	Saracatinib	10	uM	LJP6	3	D07	72	hr	1097	1734	3696	0.4691	0.2984
BT-20	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1097	2788	3735	0.7464	0.6950
BT-20	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	1097	3419	3877	0.8817	0.8664
BT-20	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	1097	3395	3925	0.8649	0.8482
BT-20	Sigma A6730	0.12	uM	LJP5	1	B23	72	hr	1097	3257	3735	0.8720	0.8508

|<
<<
Previous
Page 286 of 535
Next
>>
>
7126 to 7150 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)